Home/Filings/4/0000899243-22-036949
4//SEC Filing

Accelmed Partners II L.P. 4

Accession 0000899243-22-036949

CIK 0001528287other

Filed

Nov 22, 7:00 PM ET

Accepted

Nov 23, 5:29 PM ET

Size

6.8 KB

Accession

0000899243-22-036949

Insider Transaction Report

Form 4
Period: 2022-11-21
Transactions
  • Purchase

    Common Stock

    2022-11-21$1.50/sh+327,893$491,5124,370,550 total
  • Purchase

    Common Stock

    2022-11-22$1.50/sh+62,398$93,5354,432,948 total
Footnotes (1)
  • [F1]Shares are held by Accelmed Partners II LP. Accelmed Partners II, LLC ("Accelmed LLC") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Dr. Uri Geiger is the Managing Partner of Accelmed LLC. The address of each of Accelmed Partners II GP, LP and Accelmed Partners II LP is Ugland House, South Church Street, PO Box 309, Grand Cayman KY1-1104, Cayman Islands.

Issuer

NeuroPace Inc

CIK 0001528287

Entity typeother
IncorporatedCayman Islands

Related Parties

1
  • filerCIK 0001807256

Filing Metadata

Form type
4
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 5:29 PM ET
Size
6.8 KB